Wayne S DeVeydt
CIK 1321392 · Chief Financial Officer · last filed 2026-06-25
Wayne S DeVeydt is a Chief Financial Officer who has filed 116 SEC Form 4 insider transactions across 8 companies since 2007. The most recent filing, for UNH, was dated Jun 25, 2026. Across all open-market trades the lifetime net is −$79.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $12.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$12.01M
8
116
-$78.96M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| UNH | Chief Financial Officer | 19,778 | $428.79 | $8.48M | $0 | 6 | 2026-06-25 |
| CENTENE CORP (CNTE) Delisted | Director | 19,523 | — | — | $0 | 19 | 2025-07-02 |
| SGRY | Exec Chairman of the Board | 105,203 | $15.58 | $1.64M | -$9.79M | 19 | 2025-03-25 |
| NI | Director | 35,480 | $45.73 | $1.62M | $0 | 7 | 2021-05-26 |
| Myovant Sciences Ltd. (MYOV) Delisted | Director | — | $26.98 | — | $0 | 2 | 2017-10-20 |
| ANTX | EVP & Chief Financial Officer | 57,957 | $4.70 | $272.4K | -$1.00M | 3 | 2016-03-04 |
| Elevance Health, Inc. (ANTM) Delisted | EVP & Chief Financial Officer | 82,126 | $482.58 | $39.63M | -$18.37M | 3 | 2015-04-08 |
| Elevance Health, Inc. (WLP) Delisted | EVP & Chief Financial Officer | 128,442 | — | — | -$49.80M | 27 | 2014-11-12 |
Recent Filings
116 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-25 | UNH | Grant (A) | +111 | $0 | EDGAR |
| 2026-03-19 | UNH | Grant (A) | +149 | $0 | EDGAR |
| 2026-02-25 | UNH | Grant (A) | +8,855 | $2.50M | EDGAR |
| 2025-12-18 | UNH | Grant (A) | +70 | $0 | EDGAR |
| 2025-10-24 | SGRY | Notice (144) | −2,913 | -$65.0K | EDGAR |
| 2025-10-23 | SGRY | Notice (144) | −30,948 | -$666.2K | EDGAR |
| 2025-10-22 | SGRY | Notice (144) | −25,052 | -$532.9K | EDGAR |
| 2025-10-21 | SGRY | Notice (144) | −40,863 | -$857.5K | EDGAR |
| 2025-10-20 | SGRY | Notice (144) | −5,232 | -$109.4K | EDGAR |
| 2025-10-16 | SGRY | Notice (144) | −52,946 | -$1.13M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.